Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00223457 · ClinicalTrials.gov registry record
Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 1,040
- Enrollment target
NCT00223457: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT00223457 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,040 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00223457 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 1,040 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the coorelation between patient factors, health care provider factors, drug factors and compliance in patients with relapsing forms of multiple sclerosis (RMS) treated with Disease Modifying Agents (DMA). We hypothesize that a number of factors influence compliance with DMA's.
Interventions
- BEHAVIORAL Factors that influence compliance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,040 participants |
| Start Date | 2004-04 |
| Est. Completion | 2005-09 |
What the finished NCT00223457 record still lists
NCT00223457 is an observational study that tracks outcomes without assigning an intervention. Its 1,040 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Factors that influence compliance is the first listed.
NCT00223457 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00223457 about?
NCT00223457 is a clinical study titled "Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis". The purpose of this study is to evaluate the coorelation between patient factors, health care provider factors, drug factors and compliance in patients with relapsing forms of multiple sclerosis (RMS) treated with Disease Modifying Agents (DMA). We hypothesize that a number of factors influence comp...
What is the current status of trial NCT00223457?
This trial is currently completed. The enrollment target is 1,040 participants. The study started on 2004-04. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00223457?
The interventions under investigation include: Factors that influence compliance (BEHAVIORAL).
Who is sponsoring clinical trial NCT00223457?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05219110 · 1,040 participants · NA
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
- NCT06564948 · 1,040 participants · NA
Treatment for Individuals Interacting with the Criminal Justice System
- NCT06661720 · 1,040 participants · Phase 3
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- NCT04685616 · 1,042 participants · Phase 3
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia